Rein Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RNTX and other ETFs, options, and stocks.About RNTX
Rein Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of a novel class of therapeutics for the treatment of cancer and other diseases. It focuses on its lead product candidate, ALRN-6924, which is a cell-permeating peptide that disrupts the interaction of p53 suppressors MDM2 and MDMX with tumor suppressor p53 to reactivate tumor suppression in non-mutant, or wild-type, p53 cancers.
RNTX Key Statistics
Stock Snapshot
With a market cap of 61.84M, Rein Therapeutics(RNTX) trades at $0.71. The stock has a price-to-earnings ratio of -0.37.
On 2026-08-06, Rein Therapeutics(RNTX) stock traded between a low of $0.69 and a high of $0.78. Shares are currently priced at $0.71, which is +2.8% above the low and -8.6% below the high.
The Rein Therapeutics(RNTX)'s current trading volume is 1.1M, compared to an average daily volume of 537.16K.
During the past year, Rein Therapeutics(RNTX) stock moved between $0.69 at its lowest and $2.18 at its peak.
During the past year, Rein Therapeutics(RNTX) stock moved between $0.69 at its lowest and $2.18 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.